Chapter 2 - University of British Columbia
Chapter 2 - University of British Columbia
Chapter 2 - University of British Columbia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
264. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M,<br />
Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B et al: A large-scale RNAi screen<br />
in human cells identifies new components <strong>of</strong> the p53 pathway. Nature 2004,<br />
428(6981):431-437.<br />
265. Gobeil S, Zhu X, Doillon CJ, Green MR: A genome-wide shRNA screen identifies<br />
GAS1 as a novel melanoma metastasis suppressor gene. Genes Dev 2008,<br />
22(21):2932-2940.<br />
266. Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, Hinkle G, Boehm<br />
JS, Beroukhim R, Weir BA et al: Highly parallel identification <strong>of</strong> essential genes in<br />
cancer cells. Proc Natl Acad Sci U S A 2008, 105(51):20380-20385.<br />
267. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK,<br />
Elledge SJ: A genome-wide RNAi screen identifies multiple synthetic lethal<br />
interactions with the Ras oncogene. Cell 2009, 137(5):835-848.<br />
268. M<strong>of</strong>fat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure<br />
TM, Luo B, Grenier JK et al: A lentiviral RNAi library for human and mouse genes<br />
applied to an arrayed viral high-content screen. Cell 2006, 124(6):1283-1298.<br />
269. Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, Silver SJ, Tamayo P,<br />
Wadlow RC, Ramaswamy S et al: Synthetic lethal interaction between oncogenic<br />
KRAS dependency and STK33 suppression in human cancer cells. Cell 2009,<br />
137(5):821-834.<br />
270. Silva JM, Marran K, Parker JS, Silva J, Golding M, Schlabach MR, Elledge SJ, Hannon<br />
GJ, Chang K: Pr<strong>of</strong>iling essential genes in human mammary cells by multiplex RNAi<br />
screening. Science 2008, 319(5863):617-620.<br />
271. Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R,<br />
Kubicek M, Lottspeich F, Maser E et al: Approaching clinical proteomics: current<br />
state and future fields <strong>of</strong> application in cellular proteomics. Cytometry A 2009,<br />
75(10):816-832.<br />
272. Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R,<br />
Kubicek M, Lottspeich F, Maser E et al: Approaching clinical proteomics: current<br />
state and future fields <strong>of</strong> application in fluid proteomics. Clin Chem Lab Med 2009,<br />
47(6):724-744.<br />
273. Peng XQ, Wang F, Geng X, Zhang WM: Current advances in tumor proteomics and<br />
candidate biomarkers for hepatic cancer. Expert Rev Proteomics 2009, 6(5):551-561.<br />
274. Tainsky MA: Genomic and proteomic biomarkers for cancer: a multitude <strong>of</strong><br />
opportunities. Biochim Biophys Acta 2009, 1796(2):176-193.<br />
275. Zamo A, Cecconi D: Proteomic analysis <strong>of</strong> lymphoid and haematopoietic<br />
neoplasms: There's more than biomarker discovery. J Proteomics 2009.<br />
276. Griffin JL, Kauppinen RA: A metabolomics perspective <strong>of</strong> human brain tumours.<br />
FEBS J 2007, 274(5):1132-1139.<br />
277. Spratlin JL, Serkova NJ, Eckhardt SG: Clinical applications <strong>of</strong> metabolomics in<br />
oncology: a review. Clin Cancer Res 2009, 15(2):431-440.<br />
278. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R,<br />
Lonigro RJ, Li Y et al: Metabolomic pr<strong>of</strong>iles delineate potential role for sarcosine in<br />
prostate cancer progression. Nature 2009, 457(7231):910-914.<br />
279. Adamovic T, Trosso F, Roshani L, Andersson L, Petersen G, Rajaei S, Helou K, Levan<br />
G: Oncogene amplification in the proximal part <strong>of</strong> chromosome 6 in rat<br />
endometrial adenocarcinoma as revealed by combined BAC/PAC FISH,<br />
chromosome painting, zoo-FISH, and allelotyping. Genes Chromosomes Cancer<br />
2005, 44(2):139-153.<br />
280. Ferrandina G, Mey V, Nannizzi S, Ricciardi S, Petrillo M, Ferlini C, Danesi R, Scambia<br />
G, Del Tacca M: Expression <strong>of</strong> nucleoside transporters, deoxycitidine kinase,<br />
ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes<br />
in primary ovarian cancer. Cancer Chemother Pharmacol 2009.<br />
159